Amdocs Limited officer and director Shimie Hortig filed a Form 144 notice of proposed sale of securities on November 19, 2026, disclosing plans to sell a combined 12,897 ordinary shares across two transactions on Nasdaq.
Key Highlights
- Proposed sales: Hortig intends to sell 5,642 ordinary shares on approximately November 14, 2026, with an aggregate market value of $244,502.10, and 7,255 ordinary shares on approximately November 15, 2026, with an aggregate market value of $314,403.18.
- Broker: Both proposed sales are to be executed through Morgan Stanley Smith Barney LLC, New York.
- Shares outstanding: Amdocs Limited had 102,833,225 ordinary shares outstanding, according to the filing.
- Source of shares: The shares to be sold were acquired through vesting of restricted stock awards from Amdocs Limited, with no cash consideration paid.
- Acquisition dates: The underlying shares vested from awards originally granted on November 14, 2025, and November 15, 2024.
- Recent sales: The filing reports that Hortig sold 7,264 ordinary shares on November 10, 2026, for gross proceeds of $306,368.96, and 1,733 ordinary shares on November 11, 2026, for gross proceeds of $74,761.62.
Hortig's Proposed Transactions and Recent Sale History at Amdocs
According to the Form 144 filed with the SEC on November 19, 2026, Shimie Hortig, who is listed as both an officer and director of Amdocs Limited (NASDAQ:DOX), proposed to sell a total of 12,897 ordinary shares in two separate transactions. The first proposed sale of 5,642 shares carries an aggregate market value of $244,502.10, with an approximate sale date of November 14, 2026. The second proposed sale of 7,255 shares carries an aggregate market value of $314,403.18, with an approximate sale date of November 15, 2026. Both transactions are to be conducted on Nasdaq through Morgan Stanley Smith Barney LLC.
The filing discloses that all shares proposed for sale were acquired through restricted stock award vestings, with no cash consideration paid by Hortig. Specifically, 2,521 shares and 3,121 shares vested on November 14, 2025, and 2,261 shares and 4,994 shares vested on November 15, 2024, all granted by Amdocs Limited, according to the filing.
The filing also reports prior sales by Hortig in the three months preceding the notice date. On November 10, 2026, Hortig sold 7,264 ordinary shares for gross proceeds of $306,368.96, and on November 11, 2026, sold 1,733 ordinary shares for gross proceeds of $74,761.62. The Form 144 was signed by Shimie Hortig and is dated November 19, 2026.
What Was Disclosed
Shimie Hortig, an officer and director of Amdocs Limited, filed a Form 144 notice on November 19, 2026, proposing to sell 12,897 ordinary shares in two transactions, all sourced from restricted stock award vestings, with Amdocs having 102,833,225 shares outstanding.



Please wait processing your request...